The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Countries Tighten Travel Rules as Ebola Risk Rises

Governments are stepping up travel-related containment measures. Here is a list of screening steps and travel restrictions announced by different countries.

Episode 6: Secondary Hypertension and Renal Denervation

Drs Marwah Abdalla, Herbert Aronow, and Syed Ahsan discuss resistant hypertension, candidacy for renal denervation, and what procedural safety and follow-up look like in real-world practice.

US Puts Its Focus on Keeping Ebola Cases Out Of the Country

The United States on Wednesday said it must prevent any cases of Ebola from entering the country from the Democratic Republic of Congo, where an outbreak has already caused...

High-Sensitivity CRP a Useful Tool in Psoriatic Arthritis

New study results suggest high-sensitivity C-reactive protein may provide a more accurate picture of disease activity in patients with psoriatic arthritis.

Top Three Treatments for EoE Dysphagia Relief

Dupilumab, cendakimab, and a budesonide formulation were linked to symptomatic improvement in eosinophilic esophagitis, in a meta-analysis of 13 randomized controlled trials.

Medical Groups Redouble Infectious Disease Efforts

Specialty societies are increasingly stepping in to offer evidence and outreach in the absence of communications from federal public health officials.

Todays Updates

Sandoz Files European Complaint About Chinese Antibiotic Imports

Swiss generic drugmaker Sandoz filed a draft ⁠anti-dumping complaint with the European Commission over Chinese imports ⁠of the antibiotic ingredient amoxicillin.

Fact vs. Fallacy: Challenging the Norms of Cancer Care

Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.

T2* MRI Maps Iron in Finger Soft Tissue in Microvasculopathy

Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.

Femoral BMD May Reflect Broader Health in Older Women

An observational study suggests that bone mineral density may serve as a marker of systemic health.

Eye Inflammation Tied to Anti-Adalimumab Antibody Formation

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

Natural Supplements Linked to Cases of Severe Liver Injury

Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.

Todays Updates

Sandoz Files European Complaint About Chinese Antibiotic Imports

Swiss generic drugmaker Sandoz filed a draft ⁠anti-dumping complaint with the European Commission over Chinese imports ⁠of the antibiotic ingredient amoxicillin.

Fact vs. Fallacy: Challenging the Norms of Cancer Care

Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.

T2* MRI Maps Iron in Finger Soft Tissue in Microvasculopathy

Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.

Femoral BMD May Reflect Broader Health in Older Women

An observational study suggests that bone mineral density may serve as a marker of systemic health.

Eye Inflammation Tied to Anti-Adalimumab Antibody Formation

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

Natural Supplements Linked to Cases of Severe Liver Injury

Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.

Latest News

Governments are stepping up travel-related containment measures. Here is a list of screening steps and travel restrictions announced by different countries.

Drs Marwah Abdalla, Herbert Aronow, and Syed Ahsan discuss resistant hypertension, candidacy for renal denervation, and what procedural safety and follow-up look like in real-world practice.

The United States on Wednesday said it must prevent any cases of Ebola from entering the country from the Democratic Republic of Congo, where an outbreak has already caused...

New study results suggest high-sensitivity C-reactive protein may provide a more accurate picture of disease activity in patients with psoriatic arthritis.

Dupilumab, cendakimab, and a budesonide formulation were linked to symptomatic improvement in eosinophilic esophagitis, in a meta-analysis of 13 randomized controlled trials.

Specialty societies are increasingly stepping in to offer evidence and outreach in the absence of communications from federal public health officials.

News All Time

Analgesic Allergies Linked to Pregnancy Risks

Maternal nonnarcotic analgesic allergy labels are linked to a 60% higher risk for eclampsia and 20% higher risk for preterm birth.

Alternaria Allergy in Youth Signals Lasting Asthma Risk

Sensitization to Alternaria fungus often starts in adolescence and is linked to increased risks for persistent asthma and rhinitis, a study finds.

EU Panel Backs Wider Uses for Cancer Drugs

The EMA has backed new and expanded uses for multiple cancer drugs, signaling a push toward biomarker-driven, earlier-line care.

Interface Lets Paralyzed Patient 'Type' Faster than Ever

A paralyzed patient nearly matched the words per minute the average person can type on their phone, with 95% accuracy. See how brain-computer interface has improved.

Doctors Warn Social Media Poses Smoking-Level Health Risk

The Academy of Medical Royal Colleges has called for routine clinical screening of children's social media use in evidence to the government's online safety consultation.

FDA Approves Bulevirtide for Hepatitis Delta Virus

Bulevirtide (Hepcludex; Gilead Sciences, Inc.) is the first FDA-approved treatment for chronic hepatitis delta virus infection.

New Anaphylaxis Nasal Spray Hampered by Formulary Delays

Nearly a year after MHRA approval, many NHS practices cannot yet prescribe intranasal adrenaline for anaphylaxis.

MR Metformin and SGLT2i Now First-Line in Type 2 Diabetes

Clinicians at the Primary Care Show discuss what revised NICE guidance means for type 2 diabetes management in practice.

Reassuring Data Eases Concerns About Live Vaccines in MS

Live attenuated MMR and varicella vaccines can be administered safely before initiating high-efficacy MS therapies, potentially easing vaccine hesitancy.

Andes Virus Debate: Could Airborne Spread Play a Role?

Recent outbreaks and cruise ship exposures are renewing the debate over whether current Andes virus precautions adequately address possible respiratory spread.

What’s in the Axial Spondyloarthritis Treatment Pipeline?

Most available drugs are effective for symptom control and structural protection, but they’re not perfect and new agents are being investigated to help close the treatment gap.

US Survey Finds Sunburn Reports Common, Even With Sunscreen

More than one third of US adults in the 2024 National Health Interview Survey report experiencing at least one sunburn.

Moxifloxacin Outperforms Azithromycin in M genitalium Cure

A 10-day course of moxifloxacin 400 mg once daily demonstrates superior efficacy to a 6-day course of azithromycin 500 mg once daily for treating Mycoplasma genitalium infection.

Belimumab Linked to Lower Relapse Risk in Lupus Serositis

Despite the initial response rate to anti-inflammatory therapy in patients with systemic lupus erythematosus with serositis, relapses remain common; belimumab is linked to a lower risk for relapse.

mRNA Works Differently Than We Thought (and That’s Good)

The safety of approved mRNA vaccines is not in question, but details of their underlying biology are being revealed that could lead to better drugs.

Ontario Opts to Expand Pharmacists’ Scope of Practice

Patients in the province will be able to seek care at pharmacies for conditions like head lice, nasal congestion, dry eye, and ringworm.

Recommended News For You

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma

Only 1 in 4 Eligible Adults Receive Lung Screening

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

improvements in the treatment of prostate cancer resistant to chemotherapy.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

Can Alternating Venetoclax Regimens Improve AML Outcomes?

Recommended Articles For You

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians 

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways 

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

2.

Common intracellular toxin could help fight leukemia

3.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

4.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

5.

Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go

1.

Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment

2.

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia

3.

Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management

4.

Exploring the Hope of New Treatments for Rhabdomyosarcoma

5.

Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

3.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot